Alimera Sciences to Present at the 29th Annual ROTH Conference
March 07 2017 - 7:30AM
Alimera Sciences (NASDAQ:ALIM), a leader in the commercialization,
research and development of prescription ophthalmic
pharmaceuticals, today announced that Chief Executive Officer, Dan
Myers, will present at the 29th Annual ROTH Conference, to be held
March 12-15, 2017 at the Ritz Carlton, Orange County, CA. The
Company's presentation will take place Wednesday, March 15, 2017,
at 10:00 AM Pacific Time.
A live broadcast of the conference presentation
will be available. To access the broadcast, go to the "Investor
Relations" section of the Company's website at
www.alimerasciences.com. A replay of the conference presentation
will also be available.
About Alimera Sciences
Alimera Sciences, founded in June 2003, is a
pharmaceutical company that specializes in the commercialization,
research and development of prescription ophthalmic
pharmaceuticals. Alimera is presently focused on diseases affecting
the back of the eye, or retina, because these diseases are not well
treated with current therapies and will affect millions of people
in our aging populations. Alimera's commitment to retina
specialists and their patients is manifest in its product and in
its development portfolio designed to treat early- and late-stage
diseases. For more information, please visit
www.alimerasciences.com.
Contact:
CG CAPITAL
877.889.1972
investorrelations@cg.capital
cg.capital
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Sep 2023 to Sep 2024